Name: Avita Medical (AVH) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

AVH

Pharmaceuticals, Biotechnology & Life Sciences

Avita Medical

Short interest: 0.13%; −0.03 pp 30d; as of 9 Oct 2026
Reported shorts: 88K
Shares on issue: 69.303M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Avita Medical

Avita Medical Inc. is a regenerative medicine company specializing in therapeutic skin restoration. Their flagship product, the RECELL System, is FDA-approved for treating thermal burn wounds and full-thickness skin defects. The company leverages patient-derived skin cells to enhance healing and accelerate recovery, positioning itself as a leader in acute wound care solutions.

Company profile →

Avita Medical (ASX:AVH) has 0.13% of its shares on issue reported as short positions as of 9 Oct 2026, or about 88,026 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has fallen 0.19 percentage points. Its highest recorded short interest was 10.06% in November 2020. AVH is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads AVH today

Zanger BreakoutWatchScore 17rank 1372 of 1942
CAN SLIMWatchScore 40rank 139 of 1541
Minervini Trend TemplateTriggeredScore 89rank 1 of 1716
Crowded-Short BreakoutWatchScore 22rank 246 of 1500
Quality compoundersWatchScore 31rank 413 of 1669

Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

AVH fundamentals

In the half year to 30 Jun 2026, Avita Medical (ASX:AVH) recorded revenue of US$41.0M. Year-on-year growth: revenue +11.5% (FY). Net margin −57.0% (TTM). Figures are in USD, the company's reporting currency; source: Company filing (extracted) and Yahoo Finance, as at 13 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →